- 专利标题： TETANUS TOXOID AND CRM-BASED PEPTIDES AND METHODS OF USE
-
申请号： US17778211申请日： 2020-11-22
-
公开(公告)号： US20230211004A1公开(公告)日： 2023-07-06
- 发明人: Paeton L. WANTUCH , Jeremy A. DUKE , Fikri Y. AVCI
- 申请人： UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- 申请人地址： US GA Athens
- 专利权人： UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- 当前专利权人： UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
- 当前专利权人地址： US GA Athens
- 国际申请： PCT/US2020/061699 2020.11.22
- 进入国家日期： 2022-05-19
- 主分类号： A61K47/64
- IPC分类号： A61K47/64
摘要：
The present disclosure provides peptides derived from CRM197 and Tetanus toxoid that can be used to generate an immune response in an individual. The present disclosure includes isolated peptides and multimers of isolated peptides. Also provided are compositions that include the isolated peptide or the multimer. Further provided are methods, including methods for increasing the antigenicity of a compound, such as an antigen, and methods for inducing an immune response in a subject
信息查询
IPC分类:
